Drug Profile
CH 7057288
Alternative Names: CH-7057288Latest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Chugai Pharmaceutical
- Class Antineoplastics; Small molecules
- Mechanism of Action TrkA receptor antagonists; TrkB receptor antagonists; TrkC receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer; Lung cancer